08:00 , Dec 20, 2012 |  BC Innovations  |  Strategy

MRC Technology extends reach

After six years of focusing on developing small molecule drug candidates and humanizing therapeutic mAbs, both mostly from U.K. source, MRC Technology , the commercialization arm of the country's Medical Research Council , is taking...
07:00 , Aug 12, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Epilepsy; seizures Galanin receptor 2 (GALR2) Cell culture and mouse studies identified a nonpeptide compound that could help prevent epileptic seizures. In cells expressing GALR2,...
08:00 , Feb 18, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Indication

Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Epilepsy; seizures Galanin receptor 2 (GALR2) In vitro and mouse studies identified a GALR2-selective galanin analog that could help treat seizures. In mice, the GALR2-selective...